395 related articles for article (PubMed ID: 26681071)
1. Patient quality of life following induction of oral immunotherapy for food allergy.
Epstein Rigbi N; Katz Y; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2016 May; 27(3):263-8. PubMed ID: 26681071
[TBL] [Abstract][Full Text] [Related]
2. Changes in patient quality of life during oral immunotherapy for food allergy.
Rigbi NE; Goldberg MR; Levy MB; Nachshon L; Golobov K; Elizur A
Allergy; 2017 Dec; 72(12):1883-1890. PubMed ID: 28542911
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
[TBL] [Abstract][Full Text] [Related]
4. Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Allergy; 2020 Oct; 75(10):2623-2632. PubMed ID: 32350869
[TBL] [Abstract][Full Text] [Related]
5. Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapy.
Epstein Rigbi N; Schwartz N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2021 Jul; 32(5):1029-1037. PubMed ID: 33452829
[TBL] [Abstract][Full Text] [Related]
6. Parent perceived quality of life is age-dependent in children with food allergy.
Wassenberg J; Cochard MM; Dunngalvin A; Ballabeni P; Flokstra-de Blok BM; Newman CJ; Hofer M; Eigenmann PA
Pediatr Allergy Immunol; 2012 Aug; 23(5):412-9. PubMed ID: 22554401
[TBL] [Abstract][Full Text] [Related]
7. Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study.
Carraro S; Frigo AC; Perin M; Stefani S; Cardarelli C; Bozzetto S; Baraldi E; Zanconato S
Int J Immunopathol Pharmacol; 2012; 25(3):793-8. PubMed ID: 23058033
[TBL] [Abstract][Full Text] [Related]
8. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
DunnGalvin A; Fleischer DM; Campbell DE; O'B Hourihane J; Green TD; Sampson HA; Greenhawt M
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):216-224.e1. PubMed ID: 32841748
[TBL] [Abstract][Full Text] [Related]
9. Parents report better health-related quality of life for their food-allergic children than children themselves.
van der Velde JL; Flokstra-de Blok BM; Dunngalvin A; Hourihane JO; Duiverman EJ; Dubois AE
Clin Exp Allergy; 2011 Oct; 41(10):1431-9. PubMed ID: 21569128
[TBL] [Abstract][Full Text] [Related]
10. Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Tsviban L; Levy MB; Goldberg MR; Epstein-Rigby N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):185-192.e3. PubMed ID: 32750430
[TBL] [Abstract][Full Text] [Related]
11. Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity.
DunnGalvin A; de BlokFlokstra BM; Burks AW; Dubois AE; Hourihane JO
Clin Exp Allergy; 2008 Jun; 38(6):977-86. PubMed ID: 18435800
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Spanish version of the EuroPrevall Food Allergy Quality of Life Questionnaire-Parental Form.
Bartoll E; Nieto M; Selva B; Badillo R; Pereira G; Uixera S; Nieto A; Mazón Á
Allergol Immunopathol (Madr); 2018; 46(1):82-86. PubMed ID: 29033200
[TBL] [Abstract][Full Text] [Related]
13. Development of an Oral Immunotherapy-Related Parental Burden Scale.
Maeta A; Takaoka Y; Hamada M; Nakano A; Sumimoto S; Anzai K; Tanaka Y; Morikawa S; Kameda M; Takahashi K
Int Arch Allergy Immunol; 2023; 184(12):1203-1215. PubMed ID: 37647864
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral immunotherapy to peanut on food-specific quality of life.
Factor JM; Mendelson L; Lee J; Nouman G; Lester MR
Ann Allergy Asthma Immunol; 2012 Nov; 109(5):348-352.e2. PubMed ID: 23062391
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
16. Safety and Effectiveness of Bypassing Oral Immunotherapy Buildup With an Initial Phase of Sublingual Immunotherapy for Higher-Risk Food Allergy.
Soller L; Williams BA; Mak R; Wong T; Erdle SC; Chomyn A; Tetreault B; Morrison K; Gaudet L; Chan ES
J Allergy Clin Immunol Pract; 2024 May; 12(5):1283-1296.e2. PubMed ID: 38423293
[TBL] [Abstract][Full Text] [Related]
17. Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.
Shin S; Jang S; Kim J; Song J; Park S; Kim Y; Lee MH; Kim HM; Choi YR; Jung M; Kim M; Lee JY; Baek J; Kim S; Kim J; Ahn K
Allergy Asthma Proc; 2024 Mar; 45(2):128-136. PubMed ID: 38449018
[No Abstract] [Full Text] [Related]
18. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
[TBL] [Abstract][Full Text] [Related]
19. Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children.
Vazquez-Ortiz M; Alvaro M; Piquer M; Dominguez O; Machinena A; Martín-Mateos MA; Plaza AM
Clin Exp Allergy; 2014 Jan; 44(1):130-41. PubMed ID: 24355019
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children.
Flokstra-de Blok BM; DunnGalvin A; Vlieg-Boerstra BJ; Oude Elberink JN; Duiverman EJ; Hourihane JO; Dubois AE
Clin Exp Allergy; 2009 Jan; 39(1):127-37. PubMed ID: 19016799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
